In particular, we will be keeping an eye on the group's innovations and therefore on its investments in research and development which will enable it to stand out in the market by meeting the new needs of its customers and prospects.
Covestro is actually the result of a demerger from Bayer in 2015. This group still holds 53% of the shares in this company at that time. These shares will then drop to 24.6% in 2017 after several successive share sales. In 2018, Bayer will again sell a 10.4% stake in Covestro for 1.8 billion euros and will then only retain a 6.8% share of the capital. Covestro will then take over DSM's resin business in 2020.